Dr. ID: 59883

Stefan Steurer

graph of relations

Publications

  1. 2015
  2. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma

    Loga, K., Kohlhaussen, J., Burkhardt, L., Simon, R., Steurer, S., Burdak-Rothkamm, S., Jacobsen, F., Sauter, G. & Krech, T., 2015, In: PLOS ONE. 10, 11, p. e0141867

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

    Melling, N., Harutyunyan, L., Hube-Magg, C., Kluth, M., Simon, R., Lebok, P., Minner, S., Tsourlakis, M. C., Koop, C., Graefen, M., Adam, M., Haese, A., Wittmer, C., Steurer, S., Izbicki, J., Sauter, G., Wilczak, W., Schlomm, T. & Krech, T., 2015, In: PLOS ONE. 10, 7, p. e0134614

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

    Burdelski, C., Bujupi, E., Tsourlakis, M. C., Hube-Magg, C., Kluth, M., Melling, N., Lebok, P., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Wilczak, W., Simon, R., Schlomm, T., Steurer, S. & Krech, T., 2015, In: PLOS ONE. 10, 6, p. e0128525

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

    Burdelski, C., Menan, D., Tsourlakis, M. C., Kluth, M., Hube-Magg, C., Melling, N., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Simon, R., Schlomm, T., Steurer, S. & Krech, T., 2015, In: BMC CANCER. 15, p. 538

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

    Tsourlakis, M. C., Khosrawi, P., Weigand, P., Kluth, M., Hube-Magg, C., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Krech, T., Wilczak, W., Huland, H., Simon, R., Schlomm, T. & Steurer, S., 2015, In: INT J MOL SCI. 16, 4, p. 8591-606 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. 2014
  8. Histopathological Characteristics of Buccal Mucosa Transplants in Humans after Engraftment to the Urethra: A Prospective Study

    Soave, A., Steurer, S., Dahlem, R., Rink, M., Reiss, P., Fisch, M. & Engel, O., 01.12.2014, In: J UROLOGY. 192, 6, p. 1725-9 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays

    Steurer, S., Singer, J. M., Rink, M., Chun, F., Dahlem, R., Simon, R., Burandt, E., Stahl, P., Terracciano, L., Schlomm, T., Wagner, W., Höppner, W., Omidi, M., Kraus, O., Kwiatkowski, M., Doh, O., Fisch, M., Soave, A., Sauter, G., Wurlitzer, M., Schlüter, H. & Minner, S., 01.11.2014, In: UROL ONCOL-SEMIN ORI. 32, 8, p. 1225-33 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression

    Grupp, K., Boumesli, R., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Sauter, G., Simon, R., Izbicki, J. R., Graefen, M., Huland, H., Steurer, S., Schlomm, T., Minner, S. & Quaas, A., 15.09.2014, In: INT J CANCER. 135, 6, p. 1399-1407

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. TMPRSS2-ERG Fusions Are Strongly Linked to Young Patient Age in Low-grade Prostate Cancer

    Steurer, S., Mayer, P. S., Adam, M., Krohn, A., Koop, C., Ospina-Klinck, D., Tehrani, A. A., Simon, R., Tennstedt, P., Graefen, M., Wittmer, C., Brors, B., Plass, C., Korbel, J., Weischenfeldt, J., Sauter, G., Huland, H., Tsourlakis, M. C., Minner, S. & Schlomm, T., 08.07.2014, In: EUR UROL. 66, 6, p. 978-981

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

    Grupp, K., Ospina-Klinck, D., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Simon, R., Sauter, G., Izbicki, J. R., Graefen, M., Huland, H., Steurer, S., Schlomm, T., Minner, S. & Quaas, A., 01.07.2014, In: PROSTATE. 74, 10, p. 1012-22 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype

    Steurer, S., Seddiqi, A. S., Singer, J. M., Bahar, A. S., Eichelberg, C., Rink, M., Dahlem, R., Huland, H., Sauter, G., Simon, R., Minner, S., Burandt, E., Stahl, P. R., Schlomm, T., Wurlitzer, M. & Schlüter, H., 01.05.2014, In: ANTICANCER RES. 34, 5, p. 2255-61 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer

    Krohn, A., Freudenthaler, F., Harasimowicz, S., Kluth, M., Fuchs, S., Burkhardt, L., Stahl, P., C Tsourlakis, M., Bauer, M., Tennstedt, P., Graefen, M., Steurer, S., Sirma, H., Sauter, G., Schlomm, T., Simon, R. & Minner, S., 25.04.2014, In: MODERN PATHOL. 27, 12, p. 1612-1620

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions

    Grupp, K., Wilking, J., Prien, K., Hube-Magg, C., Sirma, H., Simon, R., Steurer, S., Budäus, L., Haese, A., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 01.03.2014, In: EUR J CANCER. 50, 4, p. 852-61 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score

    Hansen, J., Bianchi, M., Sun, M., Rink, M., Castiglione, F., Abdollah, F., Steuber, T., Ahyai, S. A., Steurer, S., Göbel, C., Freschi, M., Montorsi, F., Shariat, S. F., Fisch, M., Graefen, M., Karakiewicz, P. I., Briganti, A. & Chun, F. K-H., 01.03.2014, In: BJU INT. 113, 3, p. 399-407 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion

    Tsourlakis, M. C., Weigand, P., Grupp, K., Kluth, M., Steurer, S., Schlomm, T., Graefen, M., Huland, H., Salomon, G., Steuber, T., Wilczak, W., Sirma, H., Simon, R., Sauter, G., Minner, S. & Quaas, A., 01.03.2014, In: AM J PATHOL. 184, 3, p. 609-17 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. A Tertiary Gleason Pattern in the Prostatectomy Specimen and its Association with Adverse Outcome after Radical Prostatectomy

    Adam, M., Hannah, A., Budäus, L., Steuber, T., Salomon, G., Michl, U., Haese, A., Fisch, M., Wittmer, C., Steurer, S., Minner, S., Heinzer, H., Huland, H., Graefen, M., Sauter, G., Schlomm, T. & Isbarn, H., 08.02.2014, In: J UROLOGY. 192, 1, p. 97-101

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

    Grupp, K., Habermann, M., Sirma, H., Simon, R., Steurer, S., Hube-Magg, C., Prien, K., Burkhardt, L., Jedrzejewska, K., Salomon, G., Heinzer, H., Wilczak, W., Kluth, M., Izbicki, J. R., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 01.01.2014, In: MODERN PATHOL. 27, 1, p. 96-106 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. 2013
  21. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis

    Sirma, H., Broemel, M., Stumm, L., Tsourlakis, M. C., Steurer, S., Tennstedt, P., Salomon, G., Michl, U., Haese, A., Simon, R., Sauter, G., Schlomm, T. & Minner, S., 01.11.2013, In: ONCOL LETT. 6, 5, p. 1245-1252 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

    Grupp, K., Diebel, F., Sirma, H., Simon, R., Breitmeyer, K., Steurer, S., Hube-Magg, C., Prien, K., Pham, T., Weigand, P., Michl, U., Heinzer, H., Kluth, M., Minner, S., Tsourlakis, M. C., Izbicki, J. R., Sauter, G., Schlomm, T. & Wilczak, W., 01.11.2013, In: PROSTATE. 73, 15, p. 1690-8 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy

    Grupp, K., Höhne, T. S., Prien, K., Hube-Magg, C., Tsourlakis, M. C., Sirma, H., Pham, T., Heinzer, H., Graefen, M., Michl, U., Simon, R., Wilczak, W., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Steurer, S., 01.10.2013, In: EXP MOL PATHOL. 95, 2, p. 227-34 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

    Krohn, A., Seidel, A., Burkhardt, L., Bachmann, F., Mader, M., Grupp, K., Eichenauer, T., Becker, A., Adam, M., Graefen, M., Huland, H., Kurtz, S., Steurer, S., Tsourlakis, M. C., Minner, S., Michl, U., Schlomm, T., Sauter, G., Simon, R. & Sirma, H., 01.09.2013, In: AM J PATHOL. 231, 1, p. 130-41 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

    Kluth, M., Hesse, J., Heinl, A., Krohn, A., Steurer, S., Sirma, H., Simon, R., Mayer, P-S., Schumacher, U., Grupp, K., Izbicki, J. R., Pantel, K., Dikomey, E., Korbel, J. O., Plass, C., Sauter, G., Schlomm, T. & Minner, S., 01.07.2013, In: MODERN PATHOL. 26, 7, p. 975-83 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy

    Tsourlakis, M. C., Delmo Walter, E. M., Quaas, A., Graefen, M., Huland, H., Simon, R., Sauter, G., Steurer, S., Schlomm, T. & Minner, S., 01.06.2013, In: PROSTATE CANCER P D. 16, 2, p. 159-64 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. High mitochondria content is associated with prostate cancer disease progression

    Grupp, K., Jedrzejewska, K., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Quaas, A., Sauter, G., Simon, R., Izbicki, J. R., Graefen, M., Huland, H., Schlomm, T., Minner, S. & Steurer, S., 01.01.2013, In: MOL CANCER. 12, 1, p. 145

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.

    Grupp, K., Kohl, S., Sirma, H., Simon, R., Steurer, S., Becker, A., Adam, M., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 2013, In: MODERN PATHOL. 26, 5, p. 733-742 10 p., 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.

    Weischenfeldt, J., Simon, R., Feuerbach, L., Schlangen, K., Weichenhan, D., Minner, S., Wuttig, D., Warnatz, H-J., Stehr, H., Rausch, T., Jäger, N., Gu, L., Bogatyrova, O., Stütz, A. M., Claus, R., Eils, J., Eils, R., Gerhäuser, C., Huang, P-H., Hutter, B., Kabbe, R., Lawerenz, C., Radomski, S., Bartholomae, C. C., Fälth, M., Gade, S., Schmidt, M., Amschler, N., Hass, T., Galal, R., Gjoni, J., Kuner, R., Baer, C., Masser, S., von Kalle, C., Zichner, T., Benes, V., Raeder, B., Mader, M., Amstislavskiy, V., Avci, M., Lehrach, H., Parkhomchuk, D., Sultan, M., Burkhardt, L., Graefen, M., Huland, H., Kluth, M., Krohn, A., Sirma, H., Stumm, L., Steurer, S., Grupp, K., Sültmann, H., Sauter, G., Plass, C., Brors, B., Yaspo, M-L., Korbel, J. O. & Schlomm, T., 2013, In: CANCER CELL. 23, 2, p. 159-170 12 p., 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.

    Steurer, S., Borkowski, C., Odinga, S., Buchholz, M., Koop, C., Huland, H., Becker, M., Witt, M., Trede, D., Omidi, M., Kraus, O., Bahar, A. S., Seddiqi, A. S., Singer, J. M., Kwiatkowski, M., Trusch, M., Simon, R., Wurlitzer, M., Minner, S., Schlomm, T., Sauter, G. & Schlüter, H., 2013, In: INT J CANCER. 133, 4, p. 920-928 9 p., 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

    Stumm, L., Burkhardt, L., Steurer, S., Simon, R., Adam, M., Becker, A., Sauter, G., Minner, S., Schlomm, T., Sirma, H. & Michl, U., 2013, In: J CLIN PATHOL. 66, 7, p. 563-568 6 p., 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 3 4 Next